{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:26:51Z","timestamp":1787016411369,"version":"build-2736575974"},"reference-count":148,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1124\/jpet.123.002095","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T15:05:13Z","timestamp":1712329513000},"page":"289-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Prospect of Biomimetic Immune Cell Membrane-Coated Nanomedicines for Treatment of Serious Bacterial Infections and Sepsis"],"prefix":"10.1016","volume":"389","author":[{"given":"Alexandria","family":"Hoffman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3847-0422","authenticated-orcid":false,"given":"Victor","family":"Nizet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.123.002095_bib1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(05)60602-2","article-title":"Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock","volume":"351","author":"Abraham","year":"1998","journal-title":"Lancet"},{"key":"10.1124\/jpet.123.002095_bib2","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jama.1995.03520360048038","article-title":"Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group","volume":"273","author":"Abraham","year":"1995","journal-title":"JAMA"},{"key":"10.1124\/jpet.123.002095_bib3","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.1038\/s41598-018-24211-7","article-title":"The delta neutrophil index (DNI) as a prognostic marker for mortality in adults with sepsis: a systematic review and meta-analysis","volume":"8","author":"Ahn","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.123.002095_bib4","doi-asserted-by":"crossref","first-page":"F864","DOI":"10.1152\/ajprenal.00025.2012","article-title":"Circulating IL-6 mediates lung injury via CXCL1 production after acute kidney injury in mice","volume":"303","author":"Ahuja","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/jpet.123.002095_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0005-2736(91)90201-I","article-title":"Pharmacokinetics of stealth versus conventional liposomes: effect of dose","volume":"1068","author":"Allen","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.123.002095_bib6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0169-409X(95)00029-7","article-title":"Pharmacokinetics of long-circulating liposomes","volume":"16","author":"Allen","year":"1995","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/jpet.123.002095_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0005-2736(91)90246-5","article-title":"Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo","volume":"1066","author":"Allen","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.123.002095_bib8","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/gutjnl-2012-302152","article-title":"Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis","volume":"62","author":"Anderson","year":"2013","journal-title":"Gut"},{"key":"10.1124\/jpet.123.002095_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1034\/j.1600-0897.2002.1o023.x","article-title":"Transfer of prostasomal CD59 to CD59-deficient red blood cells results in protection against complement-mediated hemolysis","volume":"47","author":"Babiker","year":"2002","journal-title":"Am J Reprod Immunol"},{"key":"10.1124\/jpet.123.002095_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","article-title":"Diffusion of univalent ions across the lamellae of swollen phospholipids","volume":"13","author":"Bangham","year":"1965","journal-title":"J Mol Biol"},{"key":"10.1124\/jpet.123.002095_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil--the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J Control Release"},{"key":"10.1124\/jpet.123.002095_bib12","doi-asserted-by":"crossref","first-page":"6052","DOI":"10.4049\/jimmunol.171.11.6052","article-title":"Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection","volume":"171","author":"Bennouna","year":"2003","journal-title":"J Immunol"},{"key":"10.1124\/jpet.123.002095_bib13","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1056\/NEJM199703273361303","article-title":"The effects of ibuprofen on the physiology and survival of patients with sepsis","volume":"336","author":"Bernard","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.123.002095_bib14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.168.2.527","article-title":"Staphylococcal \u03b1 toxin promotes blood coagulation via attack on human platelets","volume":"168","author":"Bhakdi","year":"1988","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.123.002095_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079037","article-title":"Acute lung injury and acute kidney injury are established by four hours in experimental sepsis and are improved with pre, but not post, sepsis administration of TNF-\u03b1 antibodies","volume":"8","author":"Bhargava","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/jpet.123.002095_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202102912","article-title":"Neutrophil decoys with anti-inflammatory and anti-oxidative properties reduce secondary spinal cord injury and improve neurological functional recovery","volume":"31","author":"Bi","year":"2021","journal-title":"Adv Funct Mater"},{"key":"10.1124\/jpet.123.002095_bib17","doi-asserted-by":"crossref","first-page":"R158","DOI":"10.1186\/cc7157","article-title":"Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study","volume":"12","author":"Blanco","year":"2008","journal-title":"Crit Care"},{"key":"10.1124\/jpet.123.002095_bib18","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1172\/JCI119648","article-title":"Role of NFkappaB in the mortality of sepsis","volume":"100","author":"B\u00f6hrer","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.123.002095_bib19","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"10.1124\/jpet.123.002095_bib20","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/cc5783","article-title":"Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis","volume":"11","author":"Bozza","year":"2007","journal-title":"Crit Care"},{"key":"10.1124\/jpet.123.002095_bib21","doi-asserted-by":"crossref","first-page":"9009","DOI":"10.7150\/thno.59728","article-title":"CD4+ T cell-mimicking nanoparticles encapsulating DIABLO\/SMAC mimetics broadly neutralize HIV-1 and selectively kill HIV-1-infected cells","volume":"11","author":"Campbell","year":"2021","journal-title":"Theranostics"},{"key":"10.1124\/jpet.123.002095_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s13054-022-04204-9","article-title":"Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial","volume":"26","author":"Chastre","year":"2022","journal-title":"Crit Care"},{"key":"10.1124\/jpet.123.002095_bib23","article-title":"Broad-Spectrum Neutralization of Pore-Forming Toxins with Human Erythrocyte Membrane-Coated Nanosponges","volume":"7","author":"Chen","year":"2018","journal-title":"Adv Healthc Mater"},{"key":"10.1124\/jpet.123.002095_bib24","article-title":"Biomimetic nanosponges suppress in vivo lethality induced by the whole secreted proteins of pathogenic bacteria","volume":"15","author":"Chen","year":"2019","journal-title":"Small"},{"key":"10.1124\/jpet.123.002095_bib25","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1084\/jem.186.5.739","article-title":"Identification of human neutrophil-derived cathepsin G and azurocidin\/CAP37 as chemoattractants for mononuclear cells and neutrophils","volume":"186","author":"Chertov","year":"1997","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.123.002095_bib26","doi-asserted-by":"crossref","first-page":"17080","DOI":"10.1021\/acsnano.1c03800","article-title":"Cell membrane-coated mimics: A methodological approach for fabrication, characterization for therapeutic applications, and challenges for clinical translation","volume":"15","author":"Chugh","year":"2021","journal-title":"ACS Nano"},{"key":"10.1124\/jpet.123.002095_bib27","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1097\/00003246-199810000-00016","article-title":"Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic responses in patients with severe sepsis--a randomized, clinical trial","volume":"26","author":"Clark","year":"1998","journal-title":"Crit Care Med"},{"key":"10.1124\/jpet.123.002095_bib28","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/00003246-199609000-00002","article-title":"INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis","volume":"24","author":"Cohen","year":"1996","journal-title":"Crit Care Med"},{"key":"10.1124\/jpet.123.002095_bib29","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.4049\/jimmunol.168.11.5817","article-title":"Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney","volume":"168","author":"Cunningham","year":"2002","journal-title":"J Immunol"},{"key":"10.1124\/jpet.123.002095_bib30","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00000658-199204000-00009","article-title":"Cytokine serum level during severe sepsis in human IL-6 as a marker of severity","volume":"215","author":"Damas","year":"1992","journal-title":"Ann Surg"},{"key":"10.1124\/jpet.123.002095_bib31","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/00003246-198910000-00001","article-title":"Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans","volume":"17","author":"Damas","year":"1989","journal-title":"Crit Care Med"},{"key":"10.1124\/jpet.123.002095_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201606209","article-title":"Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization","volume":"29","author":"Dehaini","year":"2017","journal-title":"Adv Mater"},{"key":"10.1124\/jpet.123.002095_bib33","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/00003246-199509000-00004","article-title":"CDP571, a humanized antibody to human tumor necrosis factor-alpha: safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. CPD571 Sepsis Study Group","volume":"23","author":"Dhainaut","year":"1995","journal-title":"Crit Care Med"},{"key":"10.1124\/jpet.123.002095_bib34","first-page":"1272","article-title":"Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke","volume":"13","author":"Dong","year":"2019","journal-title":"ACS Nano"},{"key":"10.1124\/jpet.123.002095_bib35","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3389\/fphar.2017.00477","article-title":"A red blood cell membrane-camouflaged nanoparticle counteracts streptolysin O-mediated virulence phenotypes of invasive group A Streptococcus","volume":"8","author":"Escajadillo","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.123.002095_bib36","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1124\/jpet.123.002095_bib37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-8518-1-2","article-title":"Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model","volume":"1","author":"Faure","year":"2003","journal-title":"J Immune Based Ther Vaccines"},{"key":"10.1124\/jpet.123.002095_bib38","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJM199606273342603","article-title":"Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein","volume":"334","author":"Fisher","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.123.002095_bib39","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1001\/jama.1994.03510470040032","article-title":"Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group","volume":"271","author":"Fisher","year":"1994","journal-title":"JAMA"},{"key":"10.1124\/jpet.123.002095_bib40","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00003246-199303000-00006","article-title":"Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group","volume":"21","author":"Fisher","year":"1993","journal-title":"Crit Care Med"},{"key":"10.1124\/jpet.123.002095_bib41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00003246-199401000-00008","article-title":"Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial","volume":"22","author":"Fisher","year":"1994","journal-title":"Crit Care Med"},{"key":"10.1124\/jpet.123.002095_bib42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","article-title":"Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations","volume":"193","author":"Fleischmann","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.123.002095_bib43","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S1473-3099(20)30995-6","article-title":"Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial","volume":"21","author":"Fran\u00e7ois","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1124\/jpet.123.002095_bib44","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00134-018-5229-2","article-title":"Safety and tolerability of a single administration of AR-301, a human monoclo nal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial","volume":"44","author":"Fran\u00e7ois","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1124\/jpet.123.002095_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202102926","article-title":"An engineered pseudo-macrophage for rapid treatment of bacteria-infected osteomyelitis via microwave-excited anti-infection and immunoregulation","volume":"33","author":"Fu","year":"2021","journal-title":"Adv Mater"},{"key":"10.1124\/jpet.123.002095_bib46","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0169-409X(95)00030-B","article-title":"Liposome circulation time and tumor targeting: implications for cancer chemotherapy","volume":"16","author":"Gabizon","year":"1995","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/jpet.123.002095_bib47","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1016\/j.matt.2023.09.007","article-title":"A bacterially engineered macrophage sponge as a neutralization decoy to treat bacterial infection","volume":"6","author":"Gao","year":"2023","journal-title":"Matter"},{"key":"10.1124\/jpet.123.002095_bib48","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41467-023-44662-5","article-title":"Targeted therapies of inflammatory diseases with intracellularly gelated macrophages in mice and rats","volume":"15","author":"Gao","year":"2024","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.123.002095_bib49","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1200\/JCO.1995.13.4.996","article-title":"Phase I\/II clinical and pharmacokinetic evaluation of liposomal daunorubicin","volume":"13","author":"Gill","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1124\/jpet.123.002095_bib50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12915-017-0392-4","article-title":"Tissue macrophages: heterogeneity and functions","volume":"15","author":"Gordon","year":"2017","journal-title":"BMC Biol"},{"key":"10.1124\/jpet.123.002095_bib51","doi-asserted-by":"crossref","first-page":"58P","DOI":"10.1042\/bj1240058P","article-title":"Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases","volume":"124","author":"Gregoriadis","year":"1971","journal-title":"Biochem J"},{"key":"10.1124\/jpet.123.002095_bib52","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0005-2736(93)90105-9","article-title":"Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases","volume":"1151","author":"Haran","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.123.002095_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119128","article-title":"Coating of ferulic acid-loaded silk fibroin nanoparticles with neutrophil membranes: A promising strategy against the acute pancreatitis","volume":"270","author":"Hassanzadeh","year":"2021","journal-title":"Life Sci"},{"key":"10.1124\/jpet.123.002095_bib54","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrmicro2199","article-title":"The type III secretion system of Pseudomonas aeruginosa: infection by injection","volume":"7","author":"Hauser","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1124\/jpet.123.002095_bib55","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00003246-200203000-00005","article-title":"Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa","volume":"30","author":"Hauser","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1124\/jpet.123.002095_bib56","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1021\/acsnano.8b08964","article-title":"Erythroliposomes: integrated hybrid nanovesicles composed of erythrocyte membranes and artificial lipid membranes for pore-forming toxin clearance","volume":"13","author":"He","year":"2019","journal-title":"ACS Nano"},{"key":"10.1124\/jpet.123.002095_bib57","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nnano.2013.54","article-title":"A biomimetic nanosponge that absorbs pore-forming toxins","volume":"8","author":"Hu","year":"2013","journal-title":"Nat Nanotechnol"},{"key":"10.1124\/jpet.123.002095_bib58","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature15373","article-title":"Nanoparticle biointerfacing by platelet membrane cloaking","volume":"526","author":"Hu","year":"2015","journal-title":"Nature"},{"key":"10.1124\/jpet.123.002095_bib59","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.123.002095_bib60","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm.2451","article-title":"A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice","volume":"17","author":"Inoshima","year":"2011","journal-title":"Nat Med"},{"key":"10.1124\/jpet.123.002095_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0168-3659(02)00462-5","article-title":"Accelerated clearance of PEGylated liposomes in rats after repeated injections","volume":"88","author":"Ishida","year":"2003","journal-title":"J Control Release"},{"key":"10.1124\/jpet.123.002095_bib62","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/jama.2010.1553","article-title":"Long-term cognitive impairment and functional disability among survivors of severe sepsis","volume":"304","author":"Iwashyna","year":"2010","journal-title":"JAMA"},{"key":"10.1124\/jpet.123.002095_bib63","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cej.2019.04.032","article-title":"Endotoxin-adsorbing macrophage-mimetic hybrid liposome for sepsis treatment","volume":"371","author":"Jiang","year":"2019","journal-title":"Chem Eng J"},{"key":"10.1124\/jpet.123.002095_bib64","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.4.1.80","article-title":"Virulence factors in Escherichia coli urinary tract infection","volume":"4","author":"Johnson","year":"1991","journal-title":"Clin Microbiol Rev"},{"key":"10.1124\/jpet.123.002095_bib65","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood-2008-01-134304","article-title":"Deficiency of decay-accelerating factor and complement receptor 1-related gene\/protein y on murine platelets leads to complement-dependent clearance by the macrophage phagocytic receptor CRIg","volume":"112","author":"Kim","year":"2008","journal-title":"Blood"},{"key":"10.1124\/jpet.123.002095_bib66","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.eng.2020.09.013","article-title":"Engineered biomimetic platelet membrane-coated nanoparticles block Staphylococcus aureus cytotoxicity and protect against lethal systemic infection","volume":"7","author":"Kim","year":"2021","journal-title":"Engineering"},{"key":"10.1124\/jpet.123.002095_bib67","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-5793(90)81016-H","article-title":"Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes","volume":"268","author":"Klibanov","year":"1990","journal-title":"FEBS Lett"},{"key":"10.1124\/jpet.123.002095_bib68","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1002\/anie.200902672","article-title":"Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives","volume":"49","author":"Knop","year":"2010","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1124\/jpet.123.002095_bib69","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nri3399","article-title":"Neutrophil recruitment and function in health and inflammation","volume":"13","author":"Kolaczkowska","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/jpet.123.002095_bib70","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/368339a0","article-title":"Impaired immune and acute-phase responses in interleukin-6-deficient mice","volume":"368","author":"Kopf","year":"1994","journal-title":"Nature"},{"key":"10.1124\/jpet.123.002095_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049578","article-title":"The ability of virulence factor expression by Pseudomonas aeruginosa to predict clinical disease in hospitalized patients","volume":"7","author":"Ledizet","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/jpet.123.002095_bib72","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1055\/s-0037-1615899","article-title":"Disseminated intravascular coagulation","volume":"82","author":"Levi","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1124\/jpet.123.002095_bib73","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00134-003-1662-x","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference","volume":"29","author":"Levy","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1124\/jpet.123.002095_bib74","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3390\/cells8080881","article-title":"Size dependency of circulation and biodistribution of biomimetic nanoparticles: red blood cell membrane-coated nanoparticles","volume":"8","author":"Li","year":"2019","journal-title":"Cells"},{"key":"10.1124\/jpet.123.002095_bib75","article-title":"Bacteria activated-macrophage membrane-coated tough nanocomposite hydrogel with targeted photothermal antibacterial ability for infected wound healing","volume":"420","author":"Li","year":"2021","journal-title":"Chem Eng J"},{"key":"10.1124\/jpet.123.002095_bib76","article-title":"Coating of a novel antimicrobial nanoparticle with a macrophage membrane for the selective entry into infected macrophages and killing of intracellular staphylococci","volume":"30","author":"Li","year":"2020","journal-title":"Adv Funct Mater"},{"key":"10.1124\/jpet.123.002095_bib77","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.actbio.2023.11.026","article-title":"Rapid plasma membrane isolation via intracellular polymerization-mediated biomolecular confinement","volume":"173","author":"Lin","year":"2024","journal-title":"Acta Biomater"},{"key":"10.1124\/jpet.123.002095_bib78","article-title":"Facile transformation of murine and human primary dendritic cells into robust and modular artificial antigen-presenting systems by intracellular hydrogelation","volume":"33","author":"Lin","year":"2021","journal-title":"Adv Mater"},{"key":"10.1124\/jpet.123.002095_bib79","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cyto.2007.02.007","article-title":"Neutrophil CD64 expression and serum IL-8: sensitive early markers of severity and outcome in sepsis","volume":"36","author":"Livaditi","year":"2006","journal-title":"Cytokine"},{"key":"10.1124\/jpet.123.002095_bib80","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJMoa0907635","article-title":"Treatment with monoclonal antibodies against Clostridium difficile toxins","volume":"362","author":"Lowy","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.123.002095_bib81","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1007\/s00018-003-3020-0","article-title":"Regulation of macrophage activation","volume":"60","author":"Ma","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/jpet.123.002095_bib82","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13613-019-0495-x","article-title":"Risk factors for mortality in elderly and very elderly critically ill patients with sepsis: a prospective, observational, multicenter cohort study","volume":"9","author":"Martin-Loeches","year":"2019","journal-title":"Ann Intensive Care"},{"key":"10.1124\/jpet.123.002095_bib83","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0005-2736(86)90105-7","article-title":"Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient","volume":"857","author":"Mayer","year":"1986","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.123.002095_bib84","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1182\/blood-2016-09-741298","article-title":"Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice","volume":"129","author":"McDonald","year":"2017","journal-title":"Blood"},{"key":"10.1124\/jpet.123.002095_bib85","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s001340100888","article-title":"Evaluation of the logistic organ dysfunction system for the assessment of organ dysfunction and mortality in critically ill patients","volume":"27","author":"Metnitz","year":"2001","journal-title":"Intensive Care Med"},{"issue":"Suppl B","key":"10.1124\/jpet.123.002095_bib86","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/28.suppl_B.83","article-title":"Liposomal amphotericin B (AmBisome): safety data from a phase II\/III clinical trial","volume":"28","author":"Meunier","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1124\/jpet.123.002095_bib87","doi-asserted-by":"crossref","first-page":"13576","DOI":"10.1039\/C9NR04253A","article-title":"Macrophage-derived nanovesicles exert intrinsic anti-inflammatory properties and prolong survival in sepsis through a direct interaction with macrophages","volume":"11","author":"Molinaro","year":"2019","journal-title":"Nanoscale"},{"key":"10.1124\/jpet.123.002095_bib88","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1097\/01.CCM.0000069345.78884.0F","article-title":"Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis","volume":"31","author":"Monneret","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1124\/jpet.123.002095_bib89","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1172\/JCI115493","article-title":"Dysregulation of in vitro cytokine production by monocytes during sepsis","volume":"88","author":"Munoz","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.123.002095_bib90","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1681\/ASN.2007070744","article-title":"IL-6\/IL-6R axis plays a critical role in acute kidney injury","volume":"19","author":"Nechemia-Arbely","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.123.002095_bib91","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production","volume":"15","author":"N\u00e9meth","year":"2009","journal-title":"Nat Med"},{"key":"10.1124\/jpet.123.002095_bib92","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.it.2019.08.004","article-title":"Platelets in host defense: experimental and clinical insights","volume":"40","author":"Nicolai","year":"2019","journal-title":"Trends Immunol"},{"key":"10.1124\/jpet.123.002095_bib93","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018029","article-title":"Neutrophil to lymphocyte ratio (NLR) as a prognostic marker for in-hospital mortality of patients with sepsis: A secondary analysis based on a single-center, retrospective, cohort study","volume":"98","author":"Ni","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1124\/jpet.123.002095_bib94","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a marker of self on red blood cells","volume":"288","author":"Oldenborg","year":"2000","journal-title":"Science"},{"key":"10.1124\/jpet.123.002095_bib95","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00003246-199707000-00010","article-title":"Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group","volume":"25","author":"Opal","year":"1997","journal-title":"Crit Care Med"},{"key":"10.1124\/jpet.123.002095_bib96","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.2147\/IJN.S253125","article-title":"macrophage membrane-coated nanoparticles alleviate hepatic ischemia-reperfusion injury caused by orthotopic liver transplantation by neutralizing endotoxin","volume":"15","author":"Ou","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"10.1124\/jpet.123.002095_bib97","first-page":"645","article-title":"A clinical and experimental study of the function of neutrophils in the inflammatory response","volume":"34","author":"Page","year":"1958","journal-title":"Am J Pathol"},{"key":"10.1124\/jpet.123.002095_bib98","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1021\/acsnano.5b02132","article-title":"Detoxification of organophosphate poisoning using nanoparticle bioscavengers","volume":"9","author":"Pang","year":"2015","journal-title":"ACS Nano"},{"key":"10.1124\/jpet.123.002095_bib99","doi-asserted-by":"crossref","first-page":"R231","DOI":"10.1186\/cc11895","article-title":"Randomized double-blind placebo-controlled trial of 40 mg\/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial)","volume":"16","author":"Patel","year":"2012","journal-title":"Crit Care"},{"key":"10.1124\/jpet.123.002095_bib100","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12951-021-01130-w","article-title":"Integrated endotoxin-adsorption and antibacterial properties of platelet-membrane-coated copper silicate hollow microspheres for wound healing","volume":"19","author":"Peng","year":"2021","journal-title":"J Nanobiotechnology"},{"key":"10.1124\/jpet.123.002095_bib101","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0092-8674(93)90134-C","article-title":"Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection","volume":"73","author":"Pfeffer","year":"1993","journal-title":"Cell"},{"key":"10.1124\/jpet.123.002095_bib102","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1378\/chest.103.2.565","article-title":"Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality","volume":"103","author":"Pinsky","year":"1993","journal-title":"Chest"},{"key":"10.1124\/jpet.123.002095_bib103","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1182\/blood-2015-04-639849","article-title":"Mice expressing a mutant form of fibrinogen that cannot support fibrin formation exhibit compromised antimicrobial host defense","volume":"126","author":"Prasad","year":"2015","journal-title":"Blood"},{"key":"10.1124\/jpet.123.002095_bib104","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1128\/IAI.00115-09","article-title":"Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia","volume":"77","author":"Ragle","year":"2009","journal-title":"Infect Immun"},{"key":"10.1124\/jpet.123.002095_bib105","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1002\/smll.201502388","article-title":"Red blood cell membrane as a biomimetic nanocoating for prolonged circulation time and reduced accelerated blood clearance","volume":"11","author":"Rao","year":"2015","journal-title":"Small"},{"key":"10.1124\/jpet.123.002095_bib106","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/00003246-200104000-00015","article-title":"Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: the RAMSES study","volume":"29","author":"Reinhart","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1124\/jpet.123.002095_bib107","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00003246-199605000-00003","article-title":"Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study","volume":"24","author":"Reinhart","year":"1996","journal-title":"Crit Care Med"},{"key":"10.1124\/jpet.123.002095_bib108","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s00134-015-3906-y","article-title":"The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study)","volume":"41","author":"Rhodes","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1124\/jpet.123.002095_bib109","first-page":"260","article-title":"Definitions and pathophysiology of sepsis","volume":"43","author":"Sagy","year":"2013","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"10.1124\/jpet.123.002095_bib110","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy313","article-title":"Sepsis in intensive care unit patients: worldwide data from the Intensive Care over Nations audit","volume":"5","author":"Sakr","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1124\/jpet.123.002095_bib111","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/cc13825","article-title":"Adjuvant selenium supplementation in the form of sodium selenite in postoperative critically ill patients with severe sepsis","volume":"18","author":"Sakr","year":"2014","journal-title":"Crit Care"},{"key":"10.1124\/jpet.123.002095_bib112","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01021-15","article-title":"Staphylococcus aureus biofilms induce macrophage dysfunction through leukocidin AB and alpha-toxin","volume":"6","author":"Scherr","year":"2015","journal-title":"MBio"},{"key":"10.1124\/jpet.123.002095_bib113","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.4049\/jimmunol.136.5.1772","article-title":"Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor","volume":"136","author":"Sch\u00f6nermark","year":"1986","journal-title":"J Immunol"},{"key":"10.1124\/jpet.123.002095_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-4165(85)90174-6","article-title":"Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection","volume":"839","author":"Senior","year":"1985","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.123.002095_bib115","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1128\/IAI.72.12.6969-6977.2004","article-title":"Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung","volume":"72","author":"Shaver","year":"2004","journal-title":"Infect Immun"},{"key":"10.1124\/jpet.123.002095_bib116","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.biomaterials.2018.10.029","article-title":"Engineered nanoparticles disguised as macrophages for trapping lipopolysaccharide and preventing endotoxemia","volume":"189","author":"Shen","year":"2019","journal-title":"Biomaterials"},{"key":"10.1124\/jpet.123.002095_bib117","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/jcmm.13112","article-title":"Neutrophil dysregulation during sepsis: an overview and update","volume":"21","author":"Shen","year":"2017","journal-title":"J Cell Mol Med"},{"key":"10.1124\/jpet.123.002095_bib118","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.7150\/thno.48407","article-title":"An electroporation strategy to synthesize the membrane-coated nanoparticles for enhanced anti-inflammation therapy in bone infection","volume":"11","author":"Shi","year":"2021","journal-title":"Theranostics"},{"key":"10.1124\/jpet.123.002095_bib119","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1128\/IAI.69.5.3120-3127.2001","article-title":"Clumping factor A mediates binding of Staphylococcus aureus to human platelets","volume":"69","author":"Siboo","year":"2001","journal-title":"Infect Immun"},{"key":"10.1124\/jpet.123.002095_bib120","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1124\/jpet.123.002095_bib121","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1021\/acsami.0c18470","article-title":"Machine-learning-based approach to decode the influence of nanomaterial properties on their interaction with cells","volume":"13","author":"Singh","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1124\/jpet.123.002095_bib122","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.addr.2011.06.017","article-title":"Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention","volume":"63","author":"Szebeni","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/jpet.123.002095_bib123","doi-asserted-by":"crossref","first-page":"11488","DOI":"10.1073\/pnas.1714267114","article-title":"Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management","volume":"114","author":"Thamphiwatana","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.123.002095_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075103","article-title":"Staphylococcus aureus alpha toxin suppresses effective innate and adaptive immune responses in a murine dermonecrosis model","volume":"8","author":"Tkaczyk","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/jpet.123.002095_bib125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1128\/CVI.05589-11","article-title":"Identification of anti-alpha toxin monoclonal antibodies that reduce the severity of Staphylococcus aureus dermonecrosis and exhibit a correlation between affinity and potency","volume":"19","author":"Tkaczyk","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1124\/jpet.123.002095_bib126","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.iy.02.040184.002143","article-title":"Antigen-presenting function of the macrophage","volume":"2","author":"Unanue","year":"1984","journal-title":"Annu Rev Immunol"},{"key":"10.1124\/jpet.123.002095_bib127","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2052-0492-1-9","article-title":"Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome","volume":"1","author":"Venkata","year":"2013","journal-title":"J Intensive Care"},{"key":"10.1124\/jpet.123.002095_bib128","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"key":"10.1124\/jpet.123.002095_bib129","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.CCM.0000194725.48928.3A","article-title":"Sepsis in European intensive care units: results of the SOAP study","volume":"34","author":"Vincent","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1124\/jpet.123.002095_bib130","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201804023","article-title":"Pretreated macrophage-membrane-coated gold nanocages for precise drug delivery for treatment of bacterial infections","volume":"30","author":"Wang","year":"2018","journal-title":"Adv Mater"},{"key":"10.1124\/jpet.123.002095_bib131","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2174\/138920105774370580","article-title":"The bioreactor: a powerful tool for large-scale culture of animal cells","volume":"6","author":"Wang","year":"2005","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1124\/jpet.123.002095_bib132","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7150\/thno.47841","article-title":"Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1124\/jpet.123.002095_bib133","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201412-2323OC","article-title":"Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study","volume":"191","author":"Weiss","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.123.002095_bib134","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201802233","article-title":"T-cell-mimicking nanoparticles can neutralize HIV infectivity","volume":"30","author":"Wei","year":"2018","journal-title":"Adv Mater"},{"key":"10.1124\/jpet.123.002095_bib135","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1189\/jlb.0105017","article-title":"Leukocyte apoptosis and its significance in sepsis and shock","volume":"78","author":"Wesche","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1124\/jpet.123.002095_bib136","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.2631","article-title":"Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance","volume":"14","author":"Wong","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1124\/jpet.123.002095_bib137","series-title":"Global report on the epidemiology and burden of sepsis. Current evidence, identifying gaps and future directions.","year":"2020"},{"key":"10.1124\/jpet.123.002095_bib138","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ki.2013.286","article-title":"TNF-mediated damage to glomerular endothelium is an important determinant of acute kidney injury in sepsis","volume":"85","author":"Xu","year":"2014","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.123.002095_bib139","doi-asserted-by":"crossref","first-page":"15166","DOI":"10.1021\/acsnano.1c05618","article-title":"Biomimetic nanoparticles carrying a repolarization agent of tumor-associated macrophages for remodeling of the inflammatory microenvironment following photothermal therapy","volume":"15","author":"Yue","year":"2021","journal-title":"ACS Nano"},{"key":"10.1124\/jpet.123.002095_bib140","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1073\/pnas.83.18.6975","article-title":"Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels","volume":"83","author":"Zalman","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.123.002095_bib141","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.imlet.2013.01.004","article-title":"Staphylococcus aureus virulence factors in evasion from innate immune defenses in human and animal diseases","volume":"150","author":"Zecconi","year":"2013","journal-title":"Immunol Lett"},{"key":"10.1124\/jpet.123.002095_bib142","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00903-20","article-title":"CD4+ T Cell-mimicking nanoparticles broadly neutralize HIV-1 and suppress viral replication through autophagy","volume":"11","author":"Zhang","year":"2020","journal-title":"MBio"},{"key":"10.1124\/jpet.123.002095_bib143","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/s41565-018-0254-4","article-title":"Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis","volume":"13","author":"Zhang","year":"2018","journal-title":"Nat Nanotechnol"},{"key":"10.1124\/jpet.123.002095_bib144","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1021\/acs.nanolett.0c02278","article-title":"Cellular nanosponges inhibit SARS-CoV-2 infectivity","volume":"20","author":"Zhang","year":"2020","journal-title":"Nano Lett"},{"key":"10.1124\/jpet.123.002095_bib145","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1038\/s41467-021-24447-4","article-title":"Lure-and-kill macrophage nanoparticles alleviate the severity of experimental acute pancreatitis","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.123.002095_bib146","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41427-021-00320-0","article-title":"Simulation of nanoparticles interacting with a cell membrane: probing the structural basis and potential biomedical application","volume":"13","author":"Zhang","year":"2021","journal-title":"NPG Asia Mater"},{"key":"10.1124\/jpet.123.002095_bib147","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jconrel.2017.01.016","article-title":"Erythrocyte membrane-coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery against Staphylococcus aureus infection","volume":"263","author":"Zhang","year":"2017","journal-title":"J Control Release"},{"key":"10.1124\/jpet.123.002095_bib148","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1021\/acs.molpharmaceut.8b01342","article-title":"Inflammation-targeted delivery of celastrol via neutrophil membrane-coated nanoparticles in the management of acute pancreatitis","volume":"16","author":"Zhou","year":"2019","journal-title":"Mol Pharm"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524172564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524172564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.123.002095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:19:30Z","timestamp":1739960370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524172564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":148,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0022356524172564"],"URL":"https:\/\/doi.org\/10.1124\/jpet.123.002095","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Prospect of Biomimetic Immune Cell Membrane-Coated Nanomedicines for Treatment of Serious Bacterial Infections and Sepsis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.123.002095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}